| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.1 | 0.7 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |